K952521

Substantially Equivalent

CARDIOLIPIN IGM EIA TEST SYSTEM

Applicant
Immunoprobe, Inc.
Product code
MID
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Washington, D.C., DC, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.